European Pre-Market Summary 5th November 2026: Earnings back in focus, Maersk lifts FY guidance once again.
ORIGINAL · NewsquawkEuropean Pre-Market Summary 5th November 2026: Earnings back in focus, Maersk lifts FY guidance once again.Read originalHide original
Q3 Earnings Deutsche Telekom (DTE GY): adj. EBITDAaL beat. Affirms guidance. EUR 2bln buyback. ArcelorMittal (MT NA): Revenue miss, EBITDA beat. Crude Steel Production higher Y/Y. Affirms guidance. Ukraine charge and impairments totalling over USD 1bln during the period. Commerzbank (CBK GY): Revenue, Operating Profit and NII miss, Net Income beat. Maintains FY Net Income guidance. Maersk (MAERSKB DC): Strong Q3, upgrades FY guidance once again. Qiagen (QIA GY): Sales beat, adj. EPS in-line. Suspended guidance while the EQT transaction pends. 9M Earnings Rheinmetall (RHM GY): Metrics higher Y/Y. Cuts FY sales guidance. Veolia (VIE FP): Revenue & EBITDA higher Y/Y. FY26 outlook confirmed. Leonardo (LDO IM): Metrics higher Y/Y. Affirms FY outlook. H1 Update BT (BT/A LN): adj. EBITDA and Revenue lower Y/Y. Outlook confirmed. M&A AstraZeneca (AZN LN): USD 10bln offer to acquire Rhythm Pharmaceuticals for USD 124/shr last month, WSJ reports. ABB (ABBN SW): China has blocked SoftBank’s USD 5.4bln acquisition of ABB’s robotics division over supply chain security concerns, and despite the deal receiving Chinese competition clearance in February, the FT reports.
The 5 November summary reported mixed results and guidance updates across European companies, alongside WSJ- and FT-attributed reports of developments involving AstraZeneca, Rhythm, SoftBank and ABB.
News detail
Q3 Earnings Deutsche Telekom (DTE GY): adj. EBITDAaL beat. Affirms guidance. EUR 2bln buyback. ArcelorMittal (MT NA): Revenue miss, EBITDA beat. Crude Steel Production higher Y/Y. Affirms guidance. Ukraine charge and impairments totalling over USD 1bln during the period. Commerzbank (CBK GY): Revenue, Operating Profit and NII miss, Net Income beat. Maintains FY Net Income guidance. Maersk (MAERSKB DC): Strong Q3, upgrades FY guidance once again. Qiagen (QIA GY): Sales beat, adj. EPS in-line. Suspended guidance while the EQT transaction pends. 9M Earnings Rheinmetall (RHM GY): Metrics higher Y/Y. Cuts FY sales guidance. Veolia (VIE FP): Revenue & EBITDA higher Y/Y. FY26 outlook confirmed. Leonardo (LDO IM): Metrics higher Y/Y. Affirms FY outlook. H1 Update BT (BT/A LN): adj. EBITDA and Revenue lower Y/Y. Outlook confirmed. M&A AstraZeneca (AZN LN): USD 10bln offer to acquire Rhythm Pharmaceuticals for USD 124/shr last month, WSJ reports. ABB (ABBN SW): China has blocked SoftBank’s USD 5.4bln acquisition of ABB’s robotics division over supply chain security concerns, and despite the deal receiving Chinese competition clearance in February, the FT reports.
Related stocks
5 stocks
What do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.